The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

BACKGROUND: Because the efficacy and safety of pazopanib in Japanese patients with soft tissue sarcoma (STS) had not been evaluated previously in a large‐scale cohort, the authors investigated the efficacy and safety of pazopanib in 156 Japanese patients with relapsed STS. This was a retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tomoki, Matsumine, Akihiko, Kawai, Akira, Araki, Nobuhito, Goto, Takahiro, Yonemoto, Tsukasa, Sugiura, Hideshi, Nishida, Yoshihiro, Hiraga, Hiroaki, Honoki, Kanya, Yasuda, Taketoshi, Boku, Shogen, Sudo, Akihiro, Ueda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069581/
https://www.ncbi.nlm.nih.gov/pubmed/26970174
http://dx.doi.org/10.1002/cncr.29961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069581/
https://www.ncbi.nlm.nih.gov/pubmed/26970174
http://dx.doi.org/10.1002/cncr.29961

Ejemplares similares